Business Opportunities

NHPC may miss 11th Plan capacity addition target

State-run hydel power utility NHPC may miss its capacity addition targeted for the 11th Plan by 800 Mw, a senior company official said. - OHPC, NHPC to set up hydro projects in Orissa - U"khand wants NHPC no-objection on Lakhwar Vyasi - PSUs" peculiar problem - Power PSUs to jointly promote energy efficiency mechanisms - NHPC asks NTPC to prepare report on thermal plant in MP - Limited disinvestment in a few PSUs only for now: FM "The Parbati project is likely to have slippage and may go beyond the 11th Plan," he said. The Parbati Hydroelectric Project is a run-of-the-river scheme proposed to harness hydro potential of the lower reaches of the river Parbati in Himachal Pradesh and would generate 800 Mw. NHPC has been a given a target of adding 5,322 Mw generating capacity in the 11th Five Year Plan (2007-12). "We have already achieved 1,030 Mw of the Plan target. Another 120 MW unit is likely to be commissioned before the end of this fiscal," NHPC Executive Director (Planning) B R Saraf told reporters on the sidelines of a conference here today. The company, India"s largest hydro-electric power producer, currently has 5,475 Mw capacity under operation. It has set a target of adding roughly 4,000 Mw generating capacity in the 12th Five Year Plan (2012-17). India has set itself a target of adding 78,700 Mw capacity in the 11th Five Year Plan. The government is hopeful that the country may end up adding a capacity of 62,374 Mw, which is about 20 per cent below the original target for the plan.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

News of the day
Sunanda K Datta-Ray: It's payback time
Sunanda K Datta-Ray / New Delhi November 21, 2009, 0:08 IST
Popular Articles

Disclose commission from insurers, MFs: RBI to RRBs
To increase transparency, the Reserve Bank of India (RBI) today directed regional rural banks (RRBs) to disclose the commission they receive from mutual funds and insurers for referring their products to customers.

Taro files lawsuit against Sun in US
Israeli drug firm Taro Pharmaceuticals has filed a law suit in a US district court against Mumbai-based Sun Pharmaceutical Industries alleging violation of non-disclosure agreement and misleading shareholders.